Kangji Medical (9997 HK): Scheme Vote on 10 November
Despite a light offer, the vote risk has been lowered due to Bin Yuan/LYFE no longer being shareholders, along with the peer derating. At the last...
381 Views
Pre-IPO Lepu Biopharma - There Are Still Many Uncertainties
This article analyzed Lepu Biopharma in terms of its core product candidates in the pipeline, the challenges, concerns and future outlook for this...
445 Views
CBPO's Vote Gets Up But Dissenters Lurk
Currently trading at a gross/annualsed spread of 1.5%/7.5%. This assumes payment mid-May if assuming the negotiation process drags out to its full...
420 Views
China Biologics (CBPO US): Firm Offer Backed By Prerequisite Votes
Trading at a gross/annualised spread at 4.4%/11.7%. This looks like a pretty clean deal for around four-five months of work.
563 Views
Golden Meditech (801 HK): Prescription Renewal
Back on 13 January 2017, Golden Meditech Holdings Ltd ("GMH", 801 HK) announced an Offer from Kam Yuen, the chairman & controlling shareholder...
545 Views